Achieve Life Sciences, Inc. balance sheet

At the end of fiscal 2019, Achieve Life Sciences, Inc. had total assets of $21.1m, total liabilities of $3.0m and shareholders' equity of $18.1m. It held $16.7m in cash against $0 of debt: net cash of $16.7m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Achieve Life Sciences, Inc.: balance sheet, annual
Fiscal year	2018Dec 2018	2019Dec 2019
Cash and equivalents	10	17
Receivables	0	0
Total current assets	16	17
Goodwill	1	1
Total assets	19	21
Accounts payable	0	1
Total current liabilities	3	3
Total debt	0	0
Total liabilities	3	3
Shareholders' equity	16	18
Net debt (negative = net cash)	−10	−17

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Achieve Life Sciences, Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Achieve Life Sciences, Inc.